ÂÜÀòÂÒÂ×

Gareth Walters joined Synairgen in October 2021, and brings a wide range of experience from preclinical, to marketing authorisation, through to post-approval and commercialisation. Before joining Synairgen, Gareth served as Global Regulatory Affairs Head (Research & Early Development) and Head of European Regulatory Affairs for Chugai Pharmaceuticals, where he led strategic and operational regulatory activities in Europe, Japan and the US. Prior to his time at Chugai, he held various senior regulatory and executive management and Board roles at several pharmaceutical and biotech companies, as well as commercial and clinical positions at Roche. During this time he played a key role in bringing innovative new medicines to the market, including in the US and Europe.